Expression of HAUSP in gliomas correlates with disease progression and survival of patients

The human herpesvirus-associated ubiquitin-specific protease (HAUSP) deubiquitinating enzyme has been shown to regulate many proteins involved in the cell cycle, as well as tumor suppressors and oncogenes. However, the expression pattern of HAUSP in glioma patients is still unclear. The purpose of the present study was to investigate the expression pattern and prognostic significance of HAUSP in patients with glioma. Eighty glioma specimens and 10 normal control samples were obtained. Immunohistochemical assay, quantitative real-time PCR and western blot analysis were carried out to explore the expression of HAUSP. Additionally, the association of HAUSP expression with clinicopathological parameters and the survival of glioma patients were analyzed. Our results showed that HAUSP expression levels were increased from grade I to grade IV in the tumors of the glioma patients. Moreover, the survival rate of patients with HAUSP-positive tumors was lower when compared to that of patients with HAUSP-negative tumors. We further confirmed that high expression of HAUSP was a significant and independent prognostic indicator in glioma by multivariate analysis. Our data provide convincing evidence for the first time that the overexpression of HAUSP at the gene and protein levels is correlated with poor outcome in patients with glioma in China. HAUSP may play an important oncogenic role in glioma progression, and it is a potential diagnostic and therapeutic target.

[1]  S. Bañuelos,et al.  A global survey of CRM1-dependent nuclear export sequences in the human deubiquitinase family. , 2012, The Biochemical journal.

[2]  T. Sixma,et al.  Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase. , 2011, Molecular cell.

[3]  C. Niu,et al.  Expression of NANOG in human gliomas and its relationship with undifferentiated glioma cells. , 2011, Oncology reports.

[4]  Ivan Dikic,et al.  The spatial and temporal organization of ubiquitin networks , 2011, Nature Reviews Molecular Cell Biology.

[5]  Zhi Huang,et al.  Role of deubiquitylase HAUSP in stem cell maintenance , 2011, Cell cycle.

[6]  B. Nicholson,et al.  The Multifaceted Roles of USP7: New Therapeutic Opportunities , 2011, Cell Biochemistry and Biophysics.

[7]  C. Verrijzer,et al.  Gene expression control by protein deubiquitinases. , 2011, Current opinion in genetics & development.

[8]  René Bernards,et al.  TSPYL5 suppresses p53 levels and function by physical interaction with USP7 , 2011, Nature Cell Biology.

[9]  Yiqing Zhao,et al.  DNMT1 Stability Is Regulated by Proteins Coordinating Deubiquitination and Acetylation-Driven Ubiquitination , 2010, Science Signaling.

[10]  G. Peters,et al.  Ubiquitin-specific proteases 7 and 11 modulate Polycomb regulation of the INK4a tumour suppressor , 2010, The EMBO journal.

[11]  Erwin G. Van Meir,et al.  Exciting New Advances in Neuro‐Oncology: The Avenue to a Cure for Malignant Glioma , 2010, CA: a cancer journal for clinicians.

[12]  K. Baek,et al.  The role of deubiquitinating enzymes in apoptosis , 2010, Cellular and Molecular Life Sciences.

[13]  David Komander,et al.  Breaking the chains: structure and function of the deubiquitinases , 2009, Nature Reviews Molecular Cell Biology.

[14]  S. Gygi,et al.  Defining the Human Deubiquitinating Enzyme Interaction Landscape , 2009, Cell.

[15]  S. Jentsch,et al.  Principles of ubiquitin and SUMO modifications in DNA repair , 2009, Nature.

[16]  M. Verdier,et al.  Cancer stem cells from human glioma cell line are resistant to Fas-induced apoptosis. , 2009, International journal of oncology.

[17]  N. Mailand,et al.  USP7 counteracts SCFβTrCP- but not APCCdh1-mediated proteolysis of Claspin , 2009, The Journal of cell biology.

[18]  Guang-hui Li,et al.  Autocrine factors sustain glioblastoma stem cell self-renewal. , 2009, Oncology reports.

[19]  Pier Paolo Pandolfi,et al.  The deubiquitinylation and localization of PTEN are regulated by a HAUSP–PML network , 2008, Nature.

[20]  U. Moll,et al.  A role of HAUSP in tumor suppression in a human colon carcinoma xenograft model , 2008, Cell cycle.

[21]  M. Rapé,et al.  Reverse the curse--the role of deubiquitination in cell cycle control. , 2008, Current opinion in cell biology.

[22]  H. Clevers,et al.  Proteome changes induced by knock-down of the deubiquitylating enzyme HAUSP/USP7. , 2007, Journal of proteome research.

[23]  B. Scheithauer,et al.  The 2007 WHO classification of tumours of the central nervous system , 2007, Acta Neuropathologica.

[24]  F. Colland,et al.  FOXO4 transcriptional activity is regulated by monoubiquitination and USP7/HAUSP , 2006, Nature Cell Biology.

[25]  D. Liu,et al.  The HAUSP gene plays an important role in non‐small cell lung carcinogenesis through p53‐dependent pathways , 2006, The Journal of pathology.

[26]  Carlo Rago,et al.  Tumour suppression: Disruption of HAUSP gene stabilizes p53 , 2004, Nature.

[27]  Muyang Li,et al.  A dynamic role of HAUSP in the p53-Mdm2 pathway. , 2004, Molecular cell.

[28]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[29]  A. Ciechanover,et al.  The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. , 2002, Physiological reviews.

[30]  R. Eils,et al.  Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus , 2002, Nature Cell Biology.

[31]  A. Godzik,et al.  A Diverse Family of Proteins Containing Tumor Necrosis Factor Receptor-associated Factor Domains* , 2001, The Journal of Biological Chemistry.

[32]  Aaron Ciechanover,et al.  The ubiquitin–proteasome pathway: on protein death and cell life , 1998, The EMBO journal.

[33]  R. Everett,et al.  A novel ubiquitin‐specific protease is dynamically associated with the PML nuclear domain and binds to a herpesvirus regulatory protein , 1997, The EMBO journal.

[34]  R. Barnard,et al.  The classification of tumours of the central nervous system. , 1982, Neuropathology and applied neurobiology.

[35]  K. Yu.  Conjugation and deconjugation of ubiquitin regulating the destiny of proteins , 2022 .